RecruitingNot ApplicableNCT07073209

PENG vs Femoral Block for Hip Fracture Analgesia

PENG vs Femoral Block for Hip Fracture, A Pragmatic Cluster-Randomized Study

Sponsor

Weill Medical College of Cornell University

Enrollment

352 participants

Start Date

Jul 10, 2025

Study Type

INTERVENTIONAL

Conditions

Hip Fractures

Summary

This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated by a randomized monthly schedule, and all participants presenting during each four-week period will receive the designated block. A sub-group analysis will be performed to determine any difference in efficacy in participants with intracapsular versus extracapsular fractures.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Male or female ≥ 18 years of age.
ASA Classification 1-4
Documentation of a hip fracture diagnosis along with radiologic read indicating fracture location
Written, informed consent for analgesic peripheral block placement

Exclusion Criteria4

Altered mental status to the extent that it limits ability to report pain score
Patient or health care proxy refusal of analgesic nerve block
Allergy to study medications or contraindication to peripheral nerve block
Chronic pain diagnosis on preoperative opioids

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPENG Block Administration

Policy for the PENG block administration: 30 mL of Bupivacaine 0.25% 1:200,000 epinephrine Dexamethasone 4 mg% While these drugs are administered to participants, the intervention under evaluation is the PENG Block anesthesia technique.

PROCEDUREFemoral Block Administration

Policy for the Femoral block administration: 30 mL of Bupivacaine 0.25% 1:200,000 epinephrine Dexamethasone 4 mg While these drugs are administered to participants, the intervention under evaluation is the Femoral Block anesthesia technique.

DRUGBupivacaine , epinephrine Dexamethasone

30 mL of Bupivacaine 0.25% 1:200,000 epinephrine Dexamethasone 4 mg%

Locations(1)

Weill Cornell Medicine

Manhattan, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07073209

Related Trials

Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture

NCT050916451 location

Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures

NCT048683051 location